Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Stride, Inc. Holds Annual Stockholders Meeting
Stride, Inc. recently disclosed the outcomes of its Annual Stockholders Meeting, held on December 5, 2024. The meeting, detailed in...
Powerful 7.0 Earthquake Strikes Off Coast of Northern California; Tsunami Warning Canceled
By Jack Phillips A 7.0-magnitude earthquake struck off the coast of Northern California on Dec. 5, according to U.S. officials,...
Insider Selling: Archer Aviation Inc. (NYSE:ACHR) General Counsel Sells 114,788 Shares of Stock
Archer Aviation Inc. (NYSE:ACHR – Get Free Report) General Counsel Eric Lentell sold 114,788 shares of the company’s stock in...
Financial Comparison: GSI Technology (NASDAQ:GSIT) vs. Nano Labs (NASDAQ:NA)
Volatility & Risk GSI Technology has a beta of 0.96, indicating that its share price is 4% less volatile than...
Mark Ragosa Sells 1,123 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Stock
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) CFO Mark Ragosa sold 1,123 shares of the firm’s stock in a...
Fructose May Drive Cancer Growth: Animal Study
By George Citroner A sweetener known as fructose may give cancer tumors a boost, and researchers advise that avoiding it...